Cargando…

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

Alzheimer’s disease (AD) is the most common cause of dementia worldwide, and its prevalence is rapidly increasing due to extended lifespans. Among the increasing number of genetic risk factors identified, the apolipoprotein E (APOE) gene remains the strongest and most prevalent, impacting more than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raulin, Ana-Caroline, Doss, Sydney V., Trottier, Zachary A., Ikezu, Tadafumi C., Bu, Guojun, Liu, Chia-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644639/ https://www.ncbi.nlm.nih.gov/pubmed/36348357 http://dx.doi.org/10.1186/s13024-022-00574-4

Ejemplares similares

Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
por: Wang, Na, et al.
Publicado: (2022)

Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
por: Bu, Guojun, et al.
Publicado: (2013)

APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants
por: Bu, Guojun
Publicado: (2022)

ApoE and apoE receptors in brain lipid metabolism and AD
por: Bu, Guojun
Publicado: (2012)

An assay to evaluate the capacity of cholesterol acceptors using BODIPY-cholesterol in cells
por: Raulin, Ana-Caroline, et al.
Publicado: (2023)

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
por: Li, Zonghua, et al.
Publicado: (2020)

APOE and Alzheimer’s Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches.
por: Serrano-Pozo, Alberto, et al.
Publicado: (2021)

Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
por: Hu, Jin, et al.
Publicado: (2015)

Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
por: Tai, Leon M, et al.
Publicado: (2014)

APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology
por: Jin, Yunjung, et al.
Publicado: (2022)

The influence of ApoE4 on the clinical outcomes and pathophysiology of degenerative cervical myelopathy
por: Desimone, Alexa, et al.
Publicado: (2021)

APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids
por: Zhao, Jing, et al.
Publicado: (2023)

Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies
por: Pires, Mariana, et al.
Publicado: (2023)

ApoE4: an emerging therapeutic target for Alzheimer’s disease
por: Safieh, Mirna, et al.
Publicado: (2019)

ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
por: Lanfranco, Maria Fe, et al.
Publicado: (2020)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

The generation and function of soluble apoE receptors in the CNS
por: Rebeck, G William, et al.
Publicado: (2006)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

APOE2 is associated with longevity independent of Alzheimer’s disease
por: Shinohara, Mitsuru, et al.
Publicado: (2020)

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease
por: Inoue, Yasuteru, et al.
Publicado: (2023)

Roles of ApoE4 on the Pathogenesis in Alzheimer’s Disease and the Potential Therapeutic Approaches
por: Sun, Yu-Ying, et al.
Publicado: (2023)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

5-HT3 Antagonist Ondansetron Increases apoE Secretion by Modulating the LXR-ABCA1 Pathway
por: Shinohara, Motoko, et al.
Publicado: (2019)

Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation
por: Valencia-Olvera, Ana C., et al.
Publicado: (2023)

Standardized immunoprecipitation protocol for efficient isolation of native apolipoprotein E particles utilizing HJ15.4 monoclonal antibody
por: O’Leary, Justin, et al.
Publicado: (2023)

Commentary: Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
por: Dzianok, Patrycja, et al.
Publicado: (2020)

Protective effect of the APOE-e3 allele in Alzheimer's disease
por: de-Almada, B.V.P., et al.
Publicado: (2011)

APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer’s Disease
por: Hohman, Timothy J., et al.
Publicado: (2017)

Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease
por: Kim, Young Won, et al.
Publicado: (2020)

Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease
por: Agarwal, Rachna, et al.
Publicado: (2015)

The Molecular Basis for Apolipoprotein E4 as the Major Risk Factor for Late-Onset Alzheimer's Disease
por: Raulin, Ana-Caroline, et al.
Publicado: (2019)

Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies
por: Goldberg, Terry E., et al.
Publicado: (2020)

Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism
por: Nielsen, Henrietta M., et al.
Publicado: (2017)

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
por: Husain, Mohammed Amir, et al.
Publicado: (2021)

APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer’s disease pathophysiology
por: Tran, Tam T. T., et al.
Publicado: (2019)

Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease
por: Jun, Gyungah R., et al.
Publicado: (2022)

Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
por: Norwitz, Nicholas G., et al.
Publicado: (2021)

ApoE Alzheimer’s Disease Aβ-amyloid plaque morphology varies according to APOE isotype
por: Caesar, Ina, et al.
Publicado: (2023)

Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease
por: Patel, Kavita, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eet936tbi7dmsf1gq9lqrqn5ck